Analysis of data from the PUSH randomized trial affirmed that more fluid increase is better, but some still helps.
Multifocality is associated with an increased risk of recurrence in patients with papillary thyroid carcinoma, a ...
At a median 5-year (60.3 months) planned follow-up of the Phase 2b KEYNOTE-942/mRNA-4157-P201 study, intismeran ...
Do patients with breast cancer with a low 21-gene recurrence score need regional node irradiation to reduce their risk of locoregional recurrence? Analysis of RxPONDER data suggests only a randomized ...
Our scalable NLP system enabled us to generate real-world insights into NSCLC recurrences, paving the way for predictive models for preventing, diagnosing, and treating NSCLC recurrence. Our NLP ...
The long-term risk of distant recurrence for women with early breast cancer has declined significantly, a decades-long analysis of clinical trial data showed, largely a result of patients enrolling ...
Adjuvant radiotherapy is prescribed after breast-conserving surgery to reduce the risk of local recurrence. However, radiotherapy is inconvenient, costly, and associated with both short-term and ...
Atezolizumab, an Anti–Programmed Death-Ligand 1 Antibody, in Metastatic Renal Cell Carcinoma: Long-Term Safety, Clinical Activity, and Immune Correlates From a Phase Ia Study A total of 12,233 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results